These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32873881)

  • 21. Image analysis in high-content screening.
    Niederlein A; Meyenhofer F; White D; Bickle M
    Comb Chem High Throughput Screen; 2009 Nov; 12(9):899-907. PubMed ID: 19531001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High content analysis of phagocytic activity and cell morphology with PuntoMorph.
    Al-Ali H; Gao H; Dalby-Hansen C; Peters VA; Shi Y; Brambilla R
    J Neurosci Methods; 2017 Nov; 291():43-50. PubMed ID: 28789994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HTS assays for developing the molecular pharmacology of ion channels.
    McManus OB
    Curr Opin Pharmacol; 2014 Apr; 15():91-6. PubMed ID: 24556186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput fluorescence imaging approaches for drug discovery using in vitro and in vivo three-dimensional models.
    Martinez NJ; Titus SA; Wagner AK; Simeonov A
    Expert Opin Drug Discov; 2015 Dec; 10(12):1347-61. PubMed ID: 26394277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review article: high-throughput affinity-based technologies for small-molecule drug discovery.
    Zhu Z; Cuozzo J
    J Biomol Screen; 2009 Dec; 14(10):1157-64. PubMed ID: 19822881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilization of Multidimensional Data in the Analysis of Ultra-High-Throughput High Content Phenotypic Screens.
    Wardwell-Swanson J; Hu Y
    Methods Mol Biol; 2018; 1683():267-290. PubMed ID: 29082498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Image-Based Prediction Models of Nuclear Receptor Agonists and Antagonists Using the DeepSnap-Deep Learning Approach with the Tox21 10K Library.
    Matsuzaka Y; Uesawa Y
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Content, Phenotypic Assays and Screens for Compounds Modulating Cellular Processes in Primary Neurons.
    Kepiro M; Varkuti BH; Davis RL
    Methods Enzymol; 2018; 610():219-250. PubMed ID: 30390800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A personal perspective on high-content screening (HCS): from the beginning.
    Taylor DL
    J Biomol Screen; 2010 Aug; 15(7):720-5. PubMed ID: 20639498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a high-content screening assay panel to accelerate mechanism of action studies for oncology research.
    Towne DL; Nicholl EE; Comess KM; Galasinski SC; Hajduk PJ; Abraham VC
    J Biomol Screen; 2012 Sep; 17(8):1005-17. PubMed ID: 22706350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Image-based cell-resolved screening assays in flow.
    Cheung MC; McKenna B; Wang SS; Wolf D; Ehrlich DJ
    Cytometry A; 2015 Jun; 87(6):541-8. PubMed ID: 25515084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Dimensionality Reduction to Visualize Phenotypic Changes in High-Throughput Microscopy.
    Lu AX; Moses AM
    Methods Mol Biol; 2024; 2800():217-229. PubMed ID: 38709487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of T-Cell Migratory Phenotypes Using High-Content Analysis.
    Ng AS; Ong ST; Kelleher D; Verma NK
    Methods Mol Biol; 2019; 1930():25-32. PubMed ID: 30610595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precision multidimensional assay for high-throughput microRNA drug discovery.
    Haefliger B; Prochazka L; Angelici B; Benenson Y
    Nat Commun; 2016 Feb; 7():10709. PubMed ID: 26880188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The beautiful cell: high-content screening in drug discovery.
    Bickle M
    Anal Bioanal Chem; 2010 Sep; 398(1):219-26. PubMed ID: 20577725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing a cassette microdosing approach to enhance the throughput of PET imaging agent screening.
    Xiao H; Sun M; Zhao R; Hong H; Zhang A; Zhang S; Liu F; Zhang Y; Liu Y; Zhu L; Kung HF; Qiao J
    J Pharm Biomed Anal; 2018 May; 154():48-56. PubMed ID: 29533858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testing for drug-human serum albumin binding using fluorescent probes and other methods.
    Ronzetti M; Baljinnyam B; Yasgar A; Simeonov A
    Expert Opin Drug Discov; 2018 Nov; 13(11):1005-1014. PubMed ID: 30320522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery.
    Simm J; Klambauer G; Arany A; Steijaert M; Wegner JK; Gustin E; Chupakhin V; Chong YT; Vialard J; Buijnsters P; Velter I; Vapirev A; Singh S; Carpenter AE; Wuyts R; Hochreiter S; Moreau Y; Ceulemans H
    Cell Chem Biol; 2018 May; 25(5):611-618.e3. PubMed ID: 29503208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput liquid chromatography/mass spectrometry method for the quantitation of small molecules using accurate mass technologies in supporting discovery drug screening.
    Ding X; Ghobarah H; Zhang X; Jaochico A; Liu X; Deshmukh G; Liederer BM; Hop CE; Dean B
    Rapid Commun Mass Spectrom; 2013 Feb; 27(3):401-8. PubMed ID: 23280971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Imaging of Head and Neck Cancer Organoids.
    Shah AT; Heaster TM; Skala MC
    PLoS One; 2017; 12(1):e0170415. PubMed ID: 28099487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.